Related Experiment Video
Updated: Jul 19, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells
J Liu1, K G Suresh Kumar, D Yu
1Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104-6046, USA.
Abstract:
Mutational activation of BRAF is a frequent event in human malignant melanomas suggesting that BRAF-dependent signaling is conducive to melanoma cell growth and survival. Previously published work reported that melanoma cells exhibit constitutive anti-apoptotic nuclear factor kappaB (NF-kappaB) transcription factor activation triggered by proteolysis of its inhibitor IkappaB. IkappaB degradation is dependent upon its phosphorylation by the IkappaB kinase (IKK) complex and subsequent ubiquitination facilitated by beta-Trcp E3 ubiquitin ligase. Here, we report that melanocytes expressing a conditionally oncogenic form of BRAF(V600E) exhibit enhanced beta-Trcp expression, increased IKK activity and a concomitant increase in the rate of IkappaBalpha degradation. Conversely, inhibition of BRAF signaling using either a broad-spectrum Raf inhibitor (BAY 43-9006) or by selective knock-down of BRAF(V600E) expression by RNA interference in human melanoma cells leads to decreased IKK activity and beta-Trcp expression, stabilization of IkappaB, inhibition of NF-kappaB transcriptional activity and sensitization of these cells to apoptosis. Taken together, these data support a model in which mutational activation of BRAF in human melanomas contributes to constitutive induction of NF-kappaB activity and to increased survival of melanoma cells.
Insights
Mutant BRAF promotes melanoma cell survival by activating the NF-kappaB pathway. Inhibiting BRAF signaling reduces NF-kappaB activity, leading to melanoma cell death.
Area of Science:
- Molecular Oncology
- Cell Signaling
Background:
- BRAF mutations are common in melanoma, driving cell growth and survival.
- Melanoma cells display constitutive activation of the anti-apoptotic transcription factor NF-kappaB.
- NF-kappaB activation is regulated by IkappaB degradation, mediated by IKK and beta-Trcp.
Purpose of the Study:
- To investigate the role of BRAF signaling in regulating NF-kappaB activity in melanoma.
- To elucidate the mechanism by which BRAF influences IkappaB degradation and NF-kappaB activation.
Main Methods:
- Expression analysis of beta-Trcp in melanocytes with oncogenic BRAF.
- Assay of IKK activity and IkappaBalpha degradation rates.
- Inhibition of BRAF signaling using a Raf inhibitor (BAY 43-9006) and RNA interference.
- Assessment of NF-kappaB transcriptional activity and apoptosis induction.
Main Results:
- Oncogenic BRAF (V600E) expression enhanced beta-Trcp expression, IKK activity, and IkappaBalpha degradation.
- BRAF inhibition decreased IKK activity, beta-Trcp expression, and IkappaBalpha degradation.
- BRAF inhibition led to NF-kappaB pathway suppression and increased melanoma cell apoptosis.
Conclusions:
- Mutational activation of BRAF contributes to constitutive NF-kappaB induction in melanoma.
- BRAF signaling promotes melanoma cell survival through sustained NF-kappaB activation.
- Targeting BRAF may represent a therapeutic strategy to sensitize melanoma cells to apoptosis.
More Related Videos
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
11:02The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
Published on: August 3, 2011
Related Concept Videos
MAPK Signaling Cascades
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...